Adverse events following immunization surveillance on two types of enterovirus 71 vaccines: A real-world comparative study in China
To comprehensively assess the safety and difference of two types of EV71 vaccines: EV71-Vero, produced using Vero cells and EV71-H2, using human diploid cells. Our research included children of the recommended age who voluntarily received the EV71 vaccine in Hebei Province from 2019 to 2023. Detaile...
Saved in:
Main Authors: | Yiqing Zhu, Yihan Wang, Jinghui Wang, Yafei Wang, Li Sun, Shiheng Cui, Jing Li, Yu Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2025.2458831 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Surveillance of Adverse Events Following Varicella Vaccine Immunization in Zhejiang Province, China, from 2020 to 2022
by: Hui Liang, et al.
Published: (2025-01-01) -
A nucleoside-modified mRNA vaccine prevents enterovirus A71 infection in mouse model
by: Fengyu Chi, et al.
Published: (2025-02-01) -
Surveillance on the coverage of herpes zoster vaccine and post-marketing adverse events in Jiangsu province, China
by: Xiang Sun, et al.
Published: (2025-12-01) -
Screening of Insertion Sites and Tags on EV-A71 VP1 Protein for Recombinant Virus Construction
by: Miaomiao Kang, et al.
Published: (2025-01-01) -
Post-marketing safety surveillance for the recombinant zoster vaccine (Shingrix), vaccine adverse event reporting system, United States, October 2017–April 2024
by: Yamin Shu, et al.
Published: (2025-02-01)